Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...

Dreams are often born through the experiences that challenge and shape us, evolving from moments of personal impact into a ...

Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”) a clinical-stage biopharmaceutical company ...

SAVANNAH, Georgia — There’s no medical treatment for Charcot-Marie-Tooth (CMT) disease, a debilitating neurologic disorder ...

Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools. According to ...

A recent study suggests that a carbohydrate-rich breakfast for men and a fat-rich breakfast for women may be best for ...

Alzheimer’s Disease May Damage the Brain in Two Phases - NIH Study Uncovers Which Cell Types May Be Harmed First ...

Innate immunity represents an important arm of immune response, vital to sensing damages, pathogenic or non-pathogenic, and to repair the injury tissue. It comprehends several elements including ...

Researchers at São Paulo State University (UNESP) used concepts of condensed matter physics to describe phase separation. Their findings can have applications in the treatment of diseases.

However, the market is expected to grow significantly between 2022 and 2032, with a projected growth rate of 7%, which is ...

LVS Advisory discusses an investment they made in Medpace in the third quarter of 2024. Click here to read more about their ...

Shimadzu Corporation, Eisai Co., Ltd., Oita University, and Usuki City Medical Association have demonstrated the utility of blood biomarkers in predicting the accumulation of amyloid beta (Aβ)(1) in ...